Nordic Nanovector ASA: Mandatory notification of trade - primary insider

Thu, Oct 24, 2019 14:37 CET

Oslo, Norway, 24 October 2019

Tone Kvåle, CFO, has today, 24 October 2019, purchased 5,000 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 19.96 per share. Following this transaction, Tone Kvåle holds 45,000 PSUs, 315,000 options and 191,275 shares in the Company including shares to related party.

This information is subject to duty of disclosure pursuant to Section 4-2 and Section 5-2 of the Norwegian Securities Trading Act.

Tags:

Cancer Therapy non-hodgkins lymphoma Betalutin Nordic Nanovector Radioimmunotherapy Roy Hartvig Larsen anticancer therapeutics

Nordic Nanovector ASA: Mandatory notification of trade - primary insider

Subscribe